• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢相关性肾脏疾病中的细胞衰老:最新研究进展。

Cellular Senescence in Metabolic-Associated Kidney Disease: An Update.

机构信息

Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

出版信息

Cells. 2022 Oct 31;11(21):3443. doi: 10.3390/cells11213443.

DOI:10.3390/cells11213443
PMID:36359836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9657665/
Abstract

Cellular senescence is described as the state where the cell cycle is arrested irreversibly, which occurs in response to various forms of stress factors in cells, leading to the senescence-associated secretory phenotype (SASP). We can assess the accumulation of senescent cells in tissues or organs through biomarkers of cellular senescence such as p16, p53, p21, and SA-β-GAL. In recent decades, a large number of studies have reported the biomarkers of increased cell senescence in pathogenic tissues, demonstrating the possible connection between cell senescence and various diseases. Kidney damage often occurs in the pathophysiological process of certain metabolic diseases, resulting in metabolic-associated kidney diseases. For example, hypertension causes systemic arteriosclerosis, and the kidney can be seriously affected by abundant blood vessels, which may lead to a decreased glomerular filtration rate (GFR) and proteinuria, resulting in hypertension-related kidney diseases. The accumulation of senescent cells may also be observed in some metabolic-associated kidney diseases (such as obesity-related nephropathy, hypertension-related nephropathy, and diabetic nephropathy). In this paper, we review existing knowledge regarding the influence of cellular senescence on metabolic-associated kidney diseases, providing new ideas for future treatment.

摘要

细胞衰老被描述为细胞周期不可逆停滞的状态,这是细胞对各种形式的应激因素的反应,导致衰老相关分泌表型(SASP)。我们可以通过细胞衰老的生物标志物,如 p16、p53、p21 和 SA-β-GAL,来评估组织或器官中衰老细胞的积累。近几十年来,大量研究报告了在致病组织中细胞衰老增加的生物标志物,表明细胞衰老与各种疾病之间可能存在联系。肾脏损伤通常发生在某些代谢疾病的病理生理过程中,导致代谢相关的肾脏疾病。例如,高血压引起全身动脉硬化,肾脏可因富含血管而受到严重影响,可能导致肾小球滤过率(GFR)下降和蛋白尿,从而导致与高血压相关的肾脏疾病。在一些代谢相关的肾脏疾病(如肥胖相关的肾病、高血压相关的肾病和糖尿病肾病)中也可能观察到衰老细胞的积累。本文综述了细胞衰老对代谢相关肾脏疾病的影响,为未来的治疗提供了新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ee/9657665/65032ccb4687/cells-11-03443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ee/9657665/7dfcc93d662c/cells-11-03443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ee/9657665/65032ccb4687/cells-11-03443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ee/9657665/7dfcc93d662c/cells-11-03443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ee/9657665/65032ccb4687/cells-11-03443-g002.jpg

相似文献

1
Cellular Senescence in Metabolic-Associated Kidney Disease: An Update.代谢相关性肾脏疾病中的细胞衰老:最新研究进展。
Cells. 2022 Oct 31;11(21):3443. doi: 10.3390/cells11213443.
2
To target cellular senescence in diabetic kidney disease: the known and the unknown.针对糖尿病肾病中的细胞衰老:已知和未知。
Clin Sci (Lond). 2024 Aug 21;138(16):991-1007. doi: 10.1042/CS20240717.
3
Senescence-Associated MicroRNAs.衰老相关微小RNA
Int Rev Cell Mol Biol. 2017;334:177-205. doi: 10.1016/bs.ircmb.2017.03.008. Epub 2017 Apr 28.
4
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy.2型糖尿病肾病患者肾脏的加速衰老
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1563-73. doi: 10.1152/ajprenal.90302.2008. Epub 2008 Sep 3.
5
Developing transcriptomic signatures as a biomarker of cellular senescence.开发转录组特征作为细胞衰老的生物标志物。
Ageing Res Rev. 2024 Aug;99:102403. doi: 10.1016/j.arr.2024.102403. Epub 2024 Jul 2.
6
Techniques to Induce and Quantify Cellular Senescence.诱导和量化细胞衰老的技术
J Vis Exp. 2017 May 1(123):55533. doi: 10.3791/55533.
7
The original colorimetric method to detect cellular senescence.原用于检测细胞衰老的比色法。
Methods Cell Biol. 2024;181:59-72. doi: 10.1016/bs.mcb.2022.09.005. Epub 2022 Oct 29.
8
Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice.组织特异性衰老细胞在小鼠生理和加速衰老过程中的积累。
Aging Cell. 2020 Mar;19(3):e13094. doi: 10.1111/acel.13094. Epub 2020 Jan 25.
9
Decoy receptor 2 mediation of the senescent phenotype of tubular cells by interacting with peroxiredoxin 1 presents a novel mechanism of renal fibrosis in diabetic nephropathy.诱饵受体2通过与过氧化物还原酶1相互作用介导肾小管细胞衰老表型,这为糖尿病肾病肾纤维化提供了一种新机制。
Kidney Int. 2020 Sep;98(3):645-662. doi: 10.1016/j.kint.2020.03.026. Epub 2020 Apr 24.
10
Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.肿瘤抑制因子和衰老生物标志物 p16(INK4a) 在没有相关炎症分泌表型的情况下诱导细胞衰老。
J Biol Chem. 2011 Oct 21;286(42):36396-403. doi: 10.1074/jbc.M111.257071. Epub 2011 Aug 31.

引用本文的文献

1
The Role of Renal Cell Senescence in Diabetic Kidney Disease: Mechanisms and Therapeutic Advances.肾细胞衰老在糖尿病肾病中的作用:机制与治疗进展
Diabetes Metab Syndr Obes. 2025 Sep 8;18:3323-3341. doi: 10.2147/DMSO.S543814. eCollection 2025.
2
Xian Huang Fang Inhibits the PKCδ/MAPK Signaling Pathway to Attenuate Renal Tubular Epithelial Cell Senescence and Thereby Delay Renal Interstitial Fibrosis.仙黄方通过抑制PKCδ/MAPK信号通路减轻肾小管上皮细胞衰老从而延缓肾间质纤维化。
Drug Des Devel Ther. 2025 Aug 13;19:6991-7004. doi: 10.2147/DDDT.S522318. eCollection 2025.
3
P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism.

本文引用的文献

1
Cellular Senescence: The Villain of Metabolic Disease?: Discovery of a distinct senescent cell population in obesity-induced metabolic dysfunction.细胞衰老:代谢疾病的元凶?:在肥胖引起的代谢功能障碍中发现了一种独特的衰老细胞群体。
Mol Cells. 2022 Aug 31;45(8):531-533. doi: 10.14348/molcells.2022.0084. Epub 2022 Aug 6.
2
Cellular senescence: the good, the bad and the unknown.细胞衰老:好的、坏的和未知的。
Nat Rev Nephrol. 2022 Oct;18(10):611-627. doi: 10.1038/s41581-022-00601-z. Epub 2022 Aug 3.
3
Role of Cellular Senescence in Type II Diabetes.
P16 阳性衰老细胞通过糖酵解和线粒体代谢失调促进糖尿病肾病。
Cell Death Discov. 2025 Jul 30;11(1):355. doi: 10.1038/s41420-025-02650-2.
4
SuoquanYishen formula improves renal cellular senescence by inhibiting YTHDF1-Rubicon axis to promote autophagy in diabetic kidney disease.锁泉益肾方通过抑制YTHDF1-Rubicon轴促进糖尿病肾病中的自噬来改善肾细胞衰老。
Front Pharmacol. 2025 Apr 30;16:1543277. doi: 10.3389/fphar.2025.1543277. eCollection 2025.
5
p16INK4a Deletion Alleviated Obesity-Associated Kidney Fibrosis by Regulating Metabolic Reprogramming and the Inflammasome Pathway.p16INK4a缺失通过调节代谢重编程和炎性小体途径减轻肥胖相关的肾纤维化。
J Cell Mol Med. 2025 Mar;29(5):e70444. doi: 10.1111/jcmm.70444.
6
Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target.慢性肾脏病与衰老:剖析p53/p21信号通路作为治疗靶点
Biogerontology. 2024 Dec 26;26(1):32. doi: 10.1007/s10522-024-10173-z.
7
Targeting cellular senescence in kidney diseases and aging: A focus on mesenchymal stem cells and their paracrine factors.针对肾脏疾病和衰老中的细胞衰老:聚焦间充质干细胞及其旁分泌因子。
Cell Commun Signal. 2024 Dec 18;22(1):609. doi: 10.1186/s12964-024-01968-1.
8
Podocyte senescence: from molecular mechanisms to therapeutics.足细胞衰老:从分子机制到治疗策略。
Ren Fail. 2024 Dec;46(2):2398712. doi: 10.1080/0886022X.2024.2398712. Epub 2024 Sep 9.
9
Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets.糖尿病肾病中足细胞的死亡:潜在的分子机制和治疗靶点。
Int J Mol Sci. 2024 Aug 20;25(16):9035. doi: 10.3390/ijms25169035.
10
Cellular Senescence and Extracellular Vesicles in the Pathogenesis and Treatment of Obesity-A Narrative Review.细胞衰老与细胞外囊泡在肥胖发病机制及治疗中的作用:综述
Int J Mol Sci. 2024 Jul 20;25(14):7943. doi: 10.3390/ijms25147943.
细胞衰老在 II 型糖尿病中的作用。
Endocrinology. 2021 Oct 1;162(10). doi: 10.1210/endocr/bqab136.
4
Management of Obesity in Adults with CKD.慢性肾脏病成人患者的肥胖管理
J Am Soc Nephrol. 2021 Apr;32(4):777-790. doi: 10.1681/ASN.2020101472. Epub 2021 Feb 18.
5
The ageing kidney: Molecular mechanisms and clinical implications.衰老的肾脏:分子机制与临床意义。
Ageing Res Rev. 2020 Nov;63:101151. doi: 10.1016/j.arr.2020.101151. Epub 2020 Aug 22.
6
Cellular Senescence in the Kidney.肾脏中的细胞衰老。
J Am Soc Nephrol. 2019 May;30(5):726-736. doi: 10.1681/ASN.2018121251. Epub 2019 Apr 18.
7
"Social Life" of Senescent Cells: What Is SASP and Why Study It?衰老细胞的“社交生活”:什么是衰老相关分泌表型以及为何要研究它?
Acta Naturae. 2018 Jan-Mar;10(1):4-14.
8
Mechanisms and functions of cellular senescence.细胞衰老的机制和功能。
J Clin Invest. 2018 Apr 2;128(4):1238-1246. doi: 10.1172/JCI95148.
9
Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.肥胖或肾病相关性难治性高血压的病理生理学及潜在非药物治疗方法
Curr Hypertens Rep. 2017 Feb;19(2):18. doi: 10.1007/s11906-017-0713-6.
10
Therapeutic interventions for aging: the case of cellular senescence.衰老的治疗干预措施:以细胞衰老为例。
Drug Discov Today. 2017 May;22(5):786-795. doi: 10.1016/j.drudis.2017.01.004. Epub 2017 Jan 19.